Saotome, Kei http://orcid.org/0000-0002-4135-5356
McGoldrick, Luke L. http://orcid.org/0000-0002-8310-7502
Ho, Jo-Hao
Ramlall, Trudy F.
Shah, Sweta
Moore, Michael J.
Kim, Jee Hae
Leidich, Raymond
Olson, William C.
Franklin, Matthew C. http://orcid.org/0000-0002-1482-0136
Article History
Received: 12 September 2023
Accepted: 28 August 2024
First Online: 23 September 2024
Competing interests
: All authors are employees of Regeneron Pharmaceuticals and may own stock and/or stock options of the company. W.C.O. is an officer of Regeneron. All funding for this work was provided by Regeneron Pharmaceuticals. The anti-CXCR4 antibody described in this manuscript is a subject of international patent applications (PCT/US2024/044209 and PCT/US2024/044111).